ATRC logo

ATRC
Atricure Inc

390
Mkt Cap
$1.91B
Volume
471,828.00
52W High
$43.18
52W Low
$28.29
PE Ratio
-63.17
ATRC Fundamentals
Price
$38.41
Prev Close
$38.51
Open
$38.13
50D MA
$38.65
Beta
1.07
Avg. Volume
481,983.45
EPS (Annual)
-$0.9517
P/B
4.01
Rev/Employee
$357,928.46
Loading...
Loading...
News
all
press releases
ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures
Intuitive Surgical wins FDA 510(k) clearance for the da Vinci 5 system in select cardiac procedures to expand minimally invasive heart surgery.
Zacks·13h ago
News Placeholder
More News
News Placeholder
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...
Business Wire·18h ago
News Placeholder
Riverwater Partners LLC Buys 26,657 Shares of AtriCure, Inc. $ATRC
Riverwater Partners LLC raised its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 79.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·18h ago
News Placeholder
CLPT Gets EU MDR Certification for ClearPoint Navigation Software
ClearPoint secures EU MDR certification for ClearPoint Navigation Software 3.0.2, expanding precision-guided surgery access across MRI suites and operating rooms.
Zacks·18h ago
News Placeholder
The Zacks Analyst Blog Highlights AtriCure, REV Group, Oceaneering International and Analog Devices
AtriCure, REV Group, Oceaneering International and Analog Devices stand out after clearing a high-efficiency stock screen focused on profitability ratios.
Zacks·5d ago
News Placeholder
4 High-Efficiency Stocks Poised to Deliver Superior Returns
AtriCure tops a screen of high-efficiency stocks, joined by REV Group, Oceaneering International and Analog Devices after beating industry averages.
Zacks·6d ago
News Placeholder
SG Americas Securities LLC Has $824,000 Position in AtriCure, Inc. $ATRC
SG Americas Securities LLC lessened its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 53.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·7d ago
News Placeholder
Organon Secures FDA Approval Extending NEXPLANON Use to Five Years
OGN wins FDA approval to extend NEXPLANON use to five years, backed by trials showing no pregnancies and strong efficacy across body weights.
Zacks·8d ago
News Placeholder
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
Zacks·8d ago
News Placeholder
Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology
EKTAY jumps after FDA clears Evo CT-Linac, opening U.S. access to AI-driven CT imaging that boosts precision and efficiency in radiation therapy.
Zacks·9d ago
<
1
2
...
>

Latest ATRC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.